[Skip to Content]
[Skip to Content Landing]

Conference Presentation: Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Cluster Randomized Trial

In this randomized trial, there was no difference in ICU-acquired bloodstream infections caused by multidrug-resistant gram-negative bacteria (MDRGNB) among ventilated ICU patients given chlorhexidine 2% mouthwash, selective oropharyngeal decontamination (mouthpaste with colistin, tobramycin, and nystatin), or selective digestive tract decontamination (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. Bastiaan H. Wittekamp, MD, PhD, of University Medical Center Utrecht, the Netherlands, presents findings from the R-GNOSIS ICU trial at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.

Our websites may be periodically unavailable between 7:00pm CT December 9, 2023 and 1:00am CT December 10, 2023 for regularly scheduled maintenance.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC


Name Your Search

Save Search

Lookup An Activity


My Saved Searches

You currently have no searches saved.


My Saved Courses

You currently have no courses saved.